Koyfin Home > Directory > Health Care > Adamas Pharma > Price / Sales (ntm)

Adamas Pharma Price / Sales (ntm) Chart (ADMS)

Adamas Pharma annual/quarterly Price / Sales (ntm) from 2014 to 2020.
  • Adamas Pharma Price / Sales (ntm) for the quarter ending October 10, 2020 was 1.10 a -6.05% decrease of -0.07 year over year
  • Adamas Pharma Price / Sales (ntm) for the last 12 months ending October 10, 2020 was 1.10 a -6.05% decrease of -0.07 year over year
  • Adamas Pharma Annual Price / Sales (ntm) for 2020 was 1.10 a -0.58% decrease of -0.01 from 2019
  • Adamas Pharma Annual Price / Sales (ntm) for 2020 was 1.11 a -1.72% decrease of -0.02 from 2019
  • Adamas Pharma Annual Price / Sales (ntm) for 2020 was 1.13 a -3.66% decrease of -0.04 from 2019
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Price / Book for the quarter ending March 03, 2018 was 8.43 a 61.32% increase of 5.17 year over year
  • Adamas Pharma Enterprise Value for the quarter ending March 03, 2018 was $570m a 51.05% increase of 291m year over year
View Chart On Koyfin

Quarterly ADMS Price / Sales (ntm) Data

10/20201.10
10/20201.11
10/20201.13
10/20201.17
10/20201.23
10/20201.29
10/20201.41
10/20201.46
10/20201.52
10/20201.58

Annual ADMS Price / Sales (ntm) Data

20201.10
20201.11
20201.13
20201.17
20201.23
20201.29
20201.41
20201.46
20201.52
20201.58